Clinical Trial Update: Collection of Convalescent SARS Plasma by Apheresis

View source ↗

Summary

The trial update reports that collection of convalescent SARS plasma by apheresis has been completed under the NIAID SARS program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syndrome

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Severe Acute Respiratory Syndrome, SARS | Status: COMPLETED